The Effects of Metergoline and Other Serotonin Receptor Antagonists on Serum Corticosterone in Rats
- 1 October 1979
- journal article
- research article
- Published by The Endocrine Society in Endocrinology
- Vol. 105 (4), 923-928
- https://doi.org/10.1210/endo-105-4-923
Abstract
Metergoline antagonized the elevation of serum corticosterone by quipazine in rats. The ED50 of metergoline was less than 0.1 mg/kg, ip, and the effects of a 3 mg/kg dose persisted for more than 24 h. Metergoline did not antagonize the elevation of serum corticosterone by theophylline or ketamine {i.e. did not prevent corticosterone release nonspecifically) and did not affect the concentration of quipazineMn the brain. Since quipazine is a serotonin receptor agonist, the antagonistic effects of metergoline may have been due to competition with quipazine at serotonin receptor sites in the brain. Some other agents capable of blocking serotonin receptors also antagonized the elevation of serum corticosterone by quipazine. These included LY53857, which gave complete blockade at 3 mg/kg, and cyproheptadine and spiperone, which gave significant but incomplete antagonism at 1 mg/kg. Methysergide at 3 mg/kg did not alter the effect of quipazine. Metergoline did not antagonize the elevation of serum corticosterone by other agents throught to act via serotoninergic mechanisms, namely fluoxetine, fenfluramine, L-5-hydroxytryptophan, N,iV-dimethyl-5-methoxytryptamine, and l-(m-trifluoromethylphenyl)piperazine. Thus, the interactions between metergoline and quipazine may have occurred at receptors that are not serotonin receptors or that represent a subset of serotonin receptors not mediating the actions of serotoninergic agents other than quipazine.Keywords
This publication has 21 references indexed in Scilit:
- Effect of an Antiserotoninergic Drug, Metergoline, on the ACTH and Cortisol Response to Insulin Hypoglycemia and Lysine-Vasopressin in ManJournal of Clinical Endocrinology & Metabolism, 1976
- Pharmacologic evidence for a serotonin neural pathway involved in hypothalamus-pituitary-adrenal function in ratsLife Sciences, 1976
- The effects of quipazine on serotonin metabolism in rat brainLife Sciences, 1976
- Effects of Lilly 110140, a specific inhibitor of 5-hydroxytryptamine uptake, on food intake and on 5-hydroxytryptophan-induced anorexia. Evidence for serotoninergic inhibition of feedingJournal of Pharmacy and Pharmacology, 1976
- Effects of drugs on the processes regulating the functional activity of brain 5-hydroxytryptamineNature, 1976
- EFFECT OF VARIOUS PUTATIVE NEUROTRANSMITTERS ON THE SECRETION OF CORTICOTROPHIN-RELEASING HORMONE FROM THE RAT HYPOTHALAMUS IN VITRO – A MODEL OF THE NEUROTRANSMITTERS INVOLVEDJournal of Endocrinology, 1976
- Antinociceptive action of quipazine: Relation to central serotonergic receptor stimulationPsychopharmacology, 1976
- Effect of Metergoline, a Specific Serotonin Antagonist, on Human Growth Hormone Response to Arginine and L-DopaHormone and Metabolic Research, 1976
- Antagonism of 5-hydroxytryptamine-induced bronchospasm in guinea-pigs by 8β-carbobenzyloxy-aminomethyl-1-methyl-10α-ergolineJournal of Pharmacy and Pharmacology, 1965
- Antagonism of central effects of tryptamine and 5-hydroxytryptophan by 1,6-dimethyl-8?-carbobenzyloxy-aminomethyl-10?-ergolinePsychopharmacology, 1965